Alpha Teknova, Inc. Profile Avatar - Palmy Investing

Alpha Teknova, Inc.

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and mo…

Drug Manufacturers - Specialty & Generic
US, Hollister [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Institutional
Insider
Retail
80.45%
9.33%
10.22%
Intraday
Shares Outstanding
53,307,700
Volume
237,387
Volume on Avg.
280,444
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $7.92 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of TKNO's Analysis
CIK: 1850902 CUSIP: 02080L102 ISIN: US02080L1026 LEI: - UEI: -
Secondary Listings
TKNO has no secondary listings inside our databases.